The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

The Oncology Institute, Inc.NASDAQ: TOI

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 14.7%

Gross margin was 14.7% in Q1 FY2026, down 1.8 pp from a year earlier. On a trailing-twelve-month basis it was 14.8%, up 0.1 pp year over year. Over 3 fiscal years it narrowed by 5.4 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
14.7%-1.3 pp QoQ
Last fiscal yearDec 2025
15.2%+1.5 pp YoY
LTMMar 2026
14.8%+0.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.8 pp——
1 year+1.5 pp——
3 years-5.4 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
15.2%
Year-over-year change
+1.5pp

Gross Margin vs competitors

How TOI compares with its peers on the latest reported figures

  • TOI's LTM Mar 2026 gross margin of 14.8% is the 7th highest of the 10 companies compared; the peer median is 37.9%.
  • Its year-over-year change of +0.1 pp is the 4th highest of 10, against a peer median of -0.5 pp.
  • Over three fiscal years its change of -5.4 pp compares with a peer median of -1.1 pp.
TOI Competitors Peer median
Gross Margin for TOI and competitors
Company Period LTM level YoY 3-year change
CBLLCeriBell, Inc.LTM Mar 202687.7% +0.5 pp+5.0 pp
TMCITreace Medical Concepts, Inc.LTM Mar 202679.7% -0.5 pp-0.8 pp
KIDSOrthoPediatrics Corp.LTM Mar 202673.1% +0.3 pp-1.1 pp
EOLSEvolus, Inc.LTM Mar 202665.5% -2.3 pp+4.5 pp
AUNAAuna S.A.LTM Mar 202637.9% -1.0 pp+2.1 pp
CCRNCross Country Healthcare, Inc.LTM Mar 202619.8% -0.5 pp-3.6 pp
TOIThe Oncology Institute, Inc.LTM Mar 202614.8% +0.1 pp-5.4 pp
AGLAgilon Health, Inc.LTM Mar 2026-2.7% -2.4 pp-7.8 pp
AUTLAutolus Therapeutics plcLTM Mar 2026-11.2% +1636.4 pp-127.8 pp
SNDASonida Senior Living, Inc.LTM Mar 2026-29.9% -132.2 pp-96.5 pp
Peer median (excluding TOI) 37.9%-0.5 pp-1.1 pp

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue203M252.48M324.24M393.41M502.73M
Cost of Revenue162.16M200.39M264.67M339.42M426.29M
Gross Profit40.85M52.09M59.57M54M76.44M
Gross Margin20.1%20.6%18.4%13.7%15.2%
Research & Development00000
Selling, General & Admin0000105.57M
Operating Expenses86.71M134.04M136.59M114.12M112.52M
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
EBITDA(42.04M)(67.6M)(54.28M)(50.88M)(42.52M)
EBITDA Margin-20.7%-26.8%-16.7%-12.9%-8.5%
Operating Income(45.86M)(81.95M)(77.02M)(60.12M)(36.08M)
Operating Margin-22.6%-32.5%-23.8%-15.3%-7.2%
Interest Income00000
Interest Expense320K4.08M6.78M7.5M11.28M
Other Income / Expenses34.26M81.86M(6.09M)(4.55M)(24.65M)
Income Before Tax(11.6M)(91K)(83.1M)(64.66M)(60.74M)
Pre-Tax Margin-5.7%-0.0%-25.6%-16.4%-12.1%
Income Tax Expense(671K)(243K)(36K)0(131K)
Net Income(10.93M)152K(83.07M)(64.66M)(60.61M)
Net Margin-5.4%0.1%-25.6%-16.4%-12.1%
EPS (Basic)(0.16)0.00(0.92)(0.71)(0.54)
EPS (Diluted)(0.16)(0.21)(0.92)(0.71)(0.54)
Weighted Avg Shares66.23M72.79M73.75M75.04M923.89M
Weighted Avg Shares (Diluted)66.23M80.61M73.75M75.04M923.89M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.